Novel drug combination nanoparticles exhibit enhanced plasma exposure and dose-responsive effects on eliminating breast cancer lung metastasis is a research paper published in PLoS ONE (2020). On theSindex it has a DataRank of 0.396. It has been cited 13 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.396
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: UM1AI120176
National Institutes of Health
Grant: 1S10OD010652-01
NIAID NIH HHS
Grant: R33 AI149665
NIH HHS
Grant: S10 OD010652
NIGMS NIH HHS
Grant: T32 GM007750
NIAID NIH HHS
Grant: R61 AI149665
FWCI
0.61
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals